The Muse

I am a business economist with interests in international trade worldwide through politics, money, and banking. The author of RG Richardson City Guides has over 300 guides, including restaurants and finance.

RG Richardson Interactive

RG Richardson Interactive
Interactive Finance Dictionary

Purdue Pharma files new bankruptcy plan for $7.4 billion opioid settlement | Reuters

Purdue Pharma files new bankruptcy plan for $7.4 billion opioid settlement | Reuters
  • Sacklers to contribute $6.5-$7 billion
  • Widespread creditor support expected
  • New plan fleshes out details about how money will be allocated
NEW YORK, March 19 (Reuters) - Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step towards finalizing a proposed opioid settlement of at least $7.4 billion after a setback in the U.S. Supreme Court last year.
The payments are aimed at resolving thousands of lawsuits alleging that the company's pain medication OxyContin caused a widespread opioid addiction crisis in the United States. The headline figure had been previously flagged by Purdue and its owners, members of the wealthy Sackler family.


Comments